RINUAGENE - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Serial Number
90981040
Word Mark
RINUAGENE
Status
748 - Statement Of Use - To Examiner
Status Date
2024-05-08
Filing Date
2021-08-24
Mark Drawing
4 - Standard character mark
Published for Opposition Date
2022-08-23
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
STEEL, ALYSSA PALADINO
Statements
Goods and Services
Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary preparations for medical and pharmaceutical use, namely, preparations for preventing and treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; adjuvants for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer
Pseudo Mark
RINUA GENE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-10-10
Primary Code
005
First Use Anywhere Date
2024-02-09
First Use In Commerce Date
2024-02-09
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Eric Lamb Frost Brown Todd LLP
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2021-08-27 | NEW APPLICATION ENTERED |
| 2021-10-10 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2022-05-26 | ASSIGNED TO EXAMINER |
| 2022-06-09 | NON-FINAL ACTION WRITTEN |
| 2022-06-09 | NON-FINAL ACTION E-MAILED |
| 2022-06-09 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2022-07-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2022-07-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2022-07-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2022-07-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2022-07-15 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| 2022-07-15 | WITHDRAWAL OF ATTORNEY GRANTED |
| 2022-07-18 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2022-08-03 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2022-08-23 | PUBLISHED FOR OPPOSITION |
| 2022-08-23 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2022-10-18 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2023-03-20 | SOU TEAS EXTENSION RECEIVED |
| 2023-03-20 | SOU EXTENSION 1 FILED |
| 2023-03-20 | SOU EXTENSION 1 GRANTED |
| 2023-03-20 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2023-03-20 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2023-03-20 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2023-03-22 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2023-04-17 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2023-04-17 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2023-04-17 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2023-10-04 | ASSIGNED TO EXAMINER |
| 2023-10-11 | SOU TEAS EXTENSION RECEIVED |
| 2023-10-11 | SOU EXTENSION 2 FILED |
| 2023-10-11 | SOU EXTENSION 2 GRANTED |
| 2023-10-13 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2024-04-12 | SOU TEAS EXTENSION RECEIVED |
| 2024-04-12 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2024-04-12 | TEAS STATEMENT OF USE RECEIVED |
| 2024-04-23 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2024-04-12 | SOU EXTENSION 3 FILED |
| 2024-05-08 | SOU EXTENSION 3 GRANTED |
| 2024-04-12 | DIVISIONAL REQUEST RECEIVED |
| 2024-05-08 | DIVISIONAL PROCESSING COMPLETE |
| 2024-04-12 | USE AMENDMENT FILED |
| 2024-05-08 | STATEMENT OF USE PROCESSING COMPLETE |
